Cargando…
Determining coronavirus disease 2019 (COVID-19) community incidence threshold for preoperative testing
Preprocedural testing for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) is frequently used to reduce perioperative morbidity and mortality during the pandemic. Such testing is resource intensive, and the relative benefits depend on local epidemiology. We propose a threshold of 20 per 100...
Autores principales: | Zhou, Judy, Wituik, Christopher, Al-Salem, Mohammed, Aljarbou, Alanoud, Dekker, Jonah, Karimi, Saba, Mertz, Dominik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671915/ https://www.ncbi.nlm.nih.gov/pubmed/35968708 http://dx.doi.org/10.1017/ice.2022.206 |
Ejemplares similares
-
Incidence of Disease Flare After BNT162b2 Coronavirus Disease 2019 Vaccination in Patients With Rheumatoid Arthritis in Remission
por: Bixio, Riccardo, et al.
Publicado: (2021) -
Continued increases in the incidence of healthcare-associated infection (HAI) during the second year of the coronavirus disease 2019 (COVID-19) pandemic
por: Lastinger, Lindsey M., et al.
Publicado: (2022) -
Impact of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccination on the incidence of coronavirus disease 2019 (COVID-19) among healthcare workers at an academic medical center in Vermont
por: Noyes, Cindy D., et al.
Publicado: (2022) -
Coronavirus disease 2019: A tissue engineering and regenerative medicine perspective
por: Shafiee, Abbas, et al.
Publicado: (2020) -
Five cases of new‐onset pemphigus following vaccinations against coronavirus disease 2019
por: Corrá, Alberto, et al.
Publicado: (2022)